← Leaderboards
Carl D Novina
Massachusetts Institute Of Technology
$12,702,009
Attributed
$12,702,009
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2011–22$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$12,702,009 · 7
By mechanism
R01$7,364,349 · 4
DP1$5,210,000 · 2
F32$127,660 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Jeremy E Wilusz$5,128,345
- Jane-Jane Chen$5,525,108
- Raffaele Ferrari$6,695,665
- Roman M Lubynsky$4,301,401
- David S Jerison$1,104,369
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesBasePathway InteractionsMolecularCellsEctopic ExpressionGeneticProteinsGene TargetingAffectMalignant NeoplasmsKnock-DownTechnologySiteMutationMessenger RnaOncogenesTumorLinkTranscriptome SequencingClinical TrialsTechnology DevelopmentInnovationBiopsy
Grant awards (26)
Defining LncRNA Function in normal and Shwachman Diamond Syndrome Myelopoiesis$441,250
R01 · FY2022 · HL · contact PI
Defining LncRNA Function in normal and Shwachman Diamond Syndrome Myelopoiesis$441,250
R01 · FY2021 · HL · contact PI
Lnc'ing White Fat to Brown Fat Thermogenesis$885,000
DP1 · FY2020 · DK · contact PI
Defining LncRNA Function in normal and Shwachman Diamond Syndrome Myelopoiesis$441,250
R01 · FY2020 · HL · contact PI
Defining LncRNA Function in normal and Shwachman Diamond Syndrome Myelopoiesis$441,250
R01 · FY2019 · HL · contact PI
Engineering epigenetic therapy for sickle cell disease$865,000
DP1 · FY2018 · DK · contact PI
Engineering epigenetic therapy for sickle cell disease$865,000
DP1 · FY2017 · DK · contact PI
(PQD1) Evolution of vemurafenib resistance in circulating melanoma cells$613,546
R01 · FY2017 · CA · contact PI
Engineering epigenetic therapy for sickle cell disease$865,000
DP1 · FY2016 · DK · contact PI
(PQD1) Evolution of vemurafenib resistance in circulating melanoma cells$696,509
R01 · FY2016 · CA · contact PI
Dysregulated microRNA function in diamond blackfan anemia$347,748
R01 · FY2016 · DK · contact PI
Engineering epigenetic therapy for sickle cell disease$865,000
DP1 · FY2015 · DK · contact PI
(PQD1) Evolution of vemurafenib resistance in circulating melanoma cells$692,567
R01 · FY2015 · CA · contact PI
Dysregulated microRNA function in diamond blackfan anemia$347,748
R01 · FY2015 · DK · contact PI
Analysis of cap-dependent translational repression by microRNAs in oncogensis$326,813
R01 · FY2015 · CA · contact PI
Engineering epigenetic therapy for sickle cell disease$865,000
DP1 · FY2014 · DK · contact PI
(PQD1) Evolution of vemurafenib resistance in circulating melanoma cells$603,086
R01 · FY2014 · CA · contact PI
Dysregulated microRNA function in diamond blackfan anemia$345,766
R01 · FY2014 · DK · contact PI
Analysis of cap-dependent translational repression by microRNAs in oncogensis$317,009
R01 · FY2014 · CA · contact PI
Dysregulated microRNA function in diamond blackfan anemia$347,727
R01 · FY2013 · DK · contact PI
Analysis of cap-dependent translational repression by microRNAs in oncogensis$307,204
R01 · FY2013 · CA · contact PI
Analysis of cap-dependent translational repression by microRNAs in oncogensis$326,813
R01 · FY2012 · CA · contact PI
Analysis of cap-dependent translational repression by microRNAs in oncogensis$326,813
R01 · FY2011 · CA · contact PI
A B-CELL SPECIFIC COFACTOR OF NUCLEOSOME REMODELING$48,148
F32 · FY2002 · AI
A B-CELL SPECIFIC COFACTOR OF NUCLEOSOME REMODELING$41,996
F32 · FY2001 · AI
A B-CELL SPECIFIC COFACTOR OF NUCLEOSOME REMODELING$37,516
F32 · FY2000 · AI